1 杨孜.妊娠期高血压疾病在真实临床世界实践之辨析.中国实用妇科与产科杂志,2019,35:408-416. 2 石晛,邓芯茹,钟小翠,等.妊娠期高血压疾病相关因素分析.重庆医学,2020,49:457-462. 3 管群,林伟芳,葛佩佩.妊娠期高血压疾病发病的危险因素分析.中国妇幼保健,2021,36:884-886. 4 倪丽君.妊娠期高血压疾病对妊娠结局的影响以及相关危险因素分析.中国妇幼健康研究,2021,32:65-69. 5 Huang X,An Y,Li X,et al.Genetic variants in DICER1,DROSHA,RAN,and XPO5 genes and risk of pregnancy-induced hypertension,Pregnancy Hypertension,2019,16:1153-1161. 6 Tsakiridis I,Giouleka S,Arvanitaki A,et al.Gestational hypertension and preeclampsia:An overview of national and international guidelines.Obstet Gynecol Surv,2021,76:613-633. 7 龙青云,包婧,王小丽,等.妊娠高血压综合征患者病情严重程度与免疫、凝血功能的相关性分析.疑难病杂志,2019,18:493-497. 8 沈银,黎萍.妊娠高血压综合征患者肾脏三维超声参数与血管内皮功能的相关分析.医学研究杂志,2019,48:100-103. 9 左金玲,易建平,陈宝丽.妊娠高血压综合征基因遗传学研究进展.中国妇幼保健,2017,26:379-382. 10 符梅,许文明,覃太周,等.miRNA成熟相关基因DICER、DROSHA、RAN基因多态性与不明原因复发流产的相关性研究.四川大学学报(医学版),2017,48:880-885. 11 路旭,孙松,李玉锋,等.Dicer基因的表达与甲状腺乳头状癌的分期及转移的相关性研究.临床和实验医学杂志,2018,17:265-268. 12 Shao Y,Shen Y,Zhao L,et al.Association of microRNA biosynthesis genes XPO5 and RAN polymorphisms with cancer susceptibility:Bayesian hierarchical meta-analysis.J Cancer,2020,11:2181-2191. 13 Chen J,Qin Z,Pan S,et al.Genetic variants in RAN,DICER and HIWI of microRNA biogenesis genes and risk of cervical carcinoma in a Chinese population.Chin J Cancer Res,2013,25:565-571. 14 Takizawa T,Takahashi H,Kyi-Tha-Thu C,et al.DICER1 is present in the syncytiotrophoblast of the human full-term placenta.J Reprod Immunol,2017,16:124-137. 15 张燕,卫玲,刘媛媛,等.妊娠期高血压患者TGF-β1水平及其基因rs1800469 C/T位点多态性分析.中国优生与遗传杂志,2020,28:679-681,744. 16 赵得雄,靳紫薇,李宗英,等.妊娠期高血压患者中miRNA210表达与尿微量白蛋白/肌酐比的相关性研究.中国妇产科临床杂志,2019,20:551-552. 17 赵影庭,龚时鹏,刘玮.妊娠高血压疾病患者胎盘组织中miR-1233和HoxB3的表达水平及临床意义.河北医药,2019,41:338-342. 18 刘红超,夏亚静,姚丽辉,等.妊娠性高血压患者血清miRNA-17,miRNA-181b的水平与血压及妊娠结局关系的研究.中国优生与遗传杂志,2020,37:649-655. 19 Fawzy MS,Alsel B,Toraih EA.Analysis of microRNA processing machinery gene(DROSHA,DICER1,RAN,and XPO5) variants association with end:tage renal disease.J Clin Lab Anal,2020,16:590-601.